Gingivitis Treatment Market to Hit $2.90B by 2033 | Steady 5.5% CAGR Growth Forecast

"Fighting Gum Disease: The Growing Gingivitis Treatment Market"

AUSTIN, TX, UNITED STATES, September 26, 2025 /EINPresswire.com/ -- Market Size and Forecast

According to the DataM Intelligence: The global gingivitis treatment market size reached US$ 1.71 Billion with a rise of US$ 1.80 Billion in 2024 and is expected to reach US$ 2.90 Billion by 2033, growing at a CAGR of 5.5% during the forecast period 2025-2033.

Get a Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/gingivitis-treatment-market

Key Highlights

Regional Dominance: North America accounted for the largest revenue share of 45.5% in 2024, leading the global gingivitis treatment market.

Fastest Growth: The Asia Pacific region is projected to expand at the highest CAGR of 7.5% during the forecast period.

By Type: The Plaque-Induced Gingivitis segment emerged as the top category, capturing a 41.3% revenue share in 2024.

Leading Players: Major market participants include Micro Labs USA, Inc., Pfizer Inc., 3M, Dr. Reddy's Laboratories Ltd., Abbott Laboratories, AbbVie, GlaxoSmithKline, Zydus Cadila, and **Bausch Health Companies Inc., among others.

• Gingivitis treatment is advancing with regenerative solutions aimed at reversing early gum damage before it progresses to periodontitis. Stem cell applications and tissue engineering show promise in strengthening gum tissue. Supported by scaffolds, biomaterials, and growth factors, these techniques may provide long-lasting benefits for patients, improving recovery and disease prevention.

• The oral microbiome plays a vital role in gingivitis management. Probiotic-based approaches are emerging to restore microbial balance, reducing harmful bacteria linked to inflammation. Alongside this, minimally invasive laser therapies like LANAP can target infected tissues effectively, offering reduced pain, faster healing, and more personalized care in early-stage gum disease.

Analyst Concludes: Emerging regenerative therapies, microbiome-focused solutions, and minimally invasive laser technologies are reshaping gingivitis management by moving beyond symptomatic relief toward true disease modification. These innovations are expected to drive faster adoption, expand treatment accessibility, and create strong growth opportunities in the global gingivitis treatment market.

Drivers:

Growing awareness of oral health is a key factor driving the growth of the gingivitis treatment market. As people become more conscious of the risks associated with gum disease, they are improving daily hygiene practices and seeking early diagnosis and professional care.

This awareness fuels demand for treatments such as scaling, root planing, medicated mouthwashes, therapeutic toothpastes, and advanced procedures. Public health initiatives and government programs promoting dental hygiene further support this trend.

Educated consumers are increasingly willing to invest in preventive care and regular dental check-ups, ensuring sustained market demand. Overall, greater understanding of oral health issues encourages the adoption of innovative products and treatment options, contributing to market expansion.

For example, on March 20, 2025, World Oral Health Day emphasized the importance of oral health for overall well-being. With 3.5 billion people affected globally, the WHO called for action in Southeast Asia to raise awareness, promote preventive care, and implement strategies for healthier mouths. The FDA also backed the implementation of the WHO Regional Action Plan to achieve universal oral health coverage by 2030.

Restraints:

A shortage of skilled dental professionals is slowing the growth of the gingivitis treatment market. Limited availability of qualified dentists and dental hygienists restricts access to professional procedures such as scaling, root planing, and advanced laser treatments.

This shortage leads to longer wait times and reduced patient enrollment, while also hindering the adoption of new treatment technologies and limiting patient education and preventive care, which are critical for early detection of gingivitis. The challenge is particularly significant in rural and developing regions, constraining market penetration and growth opportunities for oral care product manufacturers and clinics.

For instance, according to CDC data published in 2024, around 57 million Americans live in areas with a shortage of dental health professionals, with approximately 67 percent of these areas located in rural communities. Between 2016 and 2021, there was also a 10 percent decline in the proportion of low-income children and adolescents (aged 1–17) who received preventive dental care during the previous year.

Recent Developments:

• For instance, in May 2023, OraPharma announced a strategic partnership with Alex Rodriguez, a renowned sports figure and health advocate, to enhance awareness about the importance of managing gum disease. This collaboration is part of the Cover Your Bases campaign, which aims to educate the public, particularly within the Hispanic community, about the prevalence and implications of gum disease."

Major Companies:

Top companies in the gingivitis treatment market include Micro Labs USA, Inc., Pfizer Inc., 3M, Dr. Reddy's Laboratories Ltd., Abbott Laboratories, AbbVie, GlaxoSmithKline, Zydus Cadila, and Bausch Health Companies Inc., among others.

Get Customization in the report as per your requirements:- https://www.datamintelligence.com/customize/gingivitis-treatment-market

Regional Analysis

North America leads the global gingivitis treatment market, capturing a 45.5% share in 2024. This dominance is driven by strong oral health awareness, advanced dental care infrastructure, and broad insurance coverage. High rates of gum disease, an aging population, and risk factors such as smoking and diabetes further fuel market demand. Robust R&D activities, frequent product innovations, and supportive regulations enhance growth, while higher disposable incomes and greater willingness to spend on oral care reinforce the region’s leadership. The U.S. holds the largest share and is expected to maintain steady growth.

For example, in the U.S., 42.2% of adults aged 30 and above suffer from periodontitis, with 7.8% experiencing severe cases and 34.4% having milder forms. Prevalence increases with age and is highest among men (50.2%), Mexican Americans (59.7%), adults below the federal poverty line (60.4%), smokers (62.4%), and individuals with diabetes (59.9%).

The Asia Pacific region is the fastest-growing market for gingivitis treatment, projected to register a CAGR of 7.5% in 2024. Growth is fueled by the rising prevalence of periodontal diseases and increasing oral health awareness across countries such as China, India, Japan, South Korea, and Australia. Expanding middle-class populations, higher disposable incomes, and greater access to modern dental care are driving demand for advanced treatment options. In Australia, government-supported oral health programs and well-established dental practices promote early diagnosis and preventive care. Meanwhile, improved healthcare infrastructure and heightened patient awareness in China and India are boosting adoption of both preventive and therapeutic gingivitis solutions.

Australia’s gingivitis treatment market continues to expand, supported by public education campaigns, an aging population, and a strong focus on preventive dental care. Initiatives such as the National Oral Health Plan, the Child Dental Benefits Schedule, and state-level programs like the Happy Teeth Program encourage timely diagnosis and treatment. Public campaigns, including Gum Disease Awareness Month and World Oral Health Day, further highlight the importance of gum health.

For example, during the Australian Dental Association’s Dental Health Week in August 2024, it was revealed that around 74% of Australian adults rarely or never floss, raising the risk of gum disease. The campaign stressed that bleeding gums are an early warning sign of serious conditions and promoted regular flossing, brushing twice daily with fluoride toothpaste, maintaining a balanced diet, and scheduling routine dental check-ups.

Market Segments

The plaque-induced gingivitis segment led the gingivitis treatment market in 2024, accounting for a 41.3% share.

The antiseptics segment is projected to hold a 40.3% share of the gingivitis treatment market in 2024.

By Type: (Plaque-Induced Gingivitis, Nutritional Gingivitis, Hormonal Gingivitis, Drug-induced Gingivitis)

By Drug Class: (Antiseptics, Antibiotics, NSAID's, Others)

By End User: (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

By Regions Covered: (North America, Europe, Asia-Pacific, South America and the Middle East & Africa)

Buy Now & Unlock 360° Market Intelligence:- https://www.datamintelligence.com/buy-now-page?report=gingivitis-treatment-market

Related Reports

Anti-Inflammatory Drugs Market

Oral Care Market

About Us:

DataM Intelligence 4Market Research is a market intelligence platform that gives access to syndicated, customized reports and consulting to its clients in one place. As a firm with rich experience in research and consulting across multiple domains, we are a one-stop solution that will cater to the needs of clients in key business areas. DataM Intelligence has an online platform whose coverage includes industries such as chemicals and materials, agriculture, health care services, animal feed, and food & beverages, among others.

Our platform has Insights on markets that uncover the latest market research data that are distinct from the competition. With coverage across 10 major industries in the marketplace research, dataM Intelligence benefits thousands of companies by helping them take their innovations early to the market, and by providing a complete view of the market with statistical forecasts. Our strategy-centric framework and value-added services will let individuals and corporates with ease of access and custom personalization to research and markets.

Author: Gundreddy Gopinadh is a healthcare research analyst with over a decade of experience in medical devices, pharmaceuticals, biotechnology, and in-vitro diagnostics (IVD). He specializes in delivering actionable insights through custom market research projects, helping organizations analyze trends, assess competitive landscapes, and uncover growth opportunities. His expertise has guided healthcare companies in product development, strategic planning, and market expansion, positioning him as a trusted contributor to data-driven innovation in the global healthcare industry.

Sai Kiran
DataM Intelligence 4Market Research LLP
+1 877-441-4866
sai.k@datamintelligence.com
Visit us on social media:
LinkedIn
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.